5 results
10-Q
2021 Q2
EX-1.1
SURF
Surface Oncology, Inc.
Quarterly report
5 Aug 21
7:06am
8-K
EX-1.1
SURF
Surface Oncology, Inc.
17 Dec 20
Surface Oncology Announces Exclusive License Agreement with GSK for Novel Immunotherapy Program
7:05am
8-K
EX-1.1
SURF
Surface Oncology, Inc.
22 May 20
Entry into a Material Definitive Agreement
4:14pm
S-3
EX-1.2
SURF
Surface Oncology, Inc.
1 May 19
Shelf registration
8:02am
S-1/A
EX-1.1
SURF
Surface Oncology, Inc.
30 Mar 18
IPO registration (amended)
12:00am
- Prev
- 1
- Next